Skip to content

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

← back to feed
Revenue (TTM)
$34.27M
+15.9% YoY Q3 Nov 2020
Net Income (TTM)
$16.27M
+295.7% YoY Q3 Nov 2020
EPS Diluted (TTM)
$2.21
+296.4% YoY Q3 Nov 2020
Gross Margin
—
Q3 Nov 2020
Operating Margin
54.9%
Q3 Nov 2020
Net Margin
47.5%
Q3 Nov 2020
Free Cash Flow (TTM)
—
Q3 Nov 2020
Cash
$2.87M
Q3 Nov 2020
Total Debt
—
Q3 Nov 2020
Shares Outstanding
7.34M sh
Q3 Nov 2020

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings